Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v1-EN
Language English English
Date Updated 2020-09-17 2020-09-02
Drug Identification Number 02485478 02485478
Brand name CLINDAMYCIN INJECTION IN 5% DEXTROSE CLINDAMYCIN INJECTION IN 5% DEXTROSE
Common or Proper name CLINDAMYCIN INJECTION IN 5% DEXTROSE CLINDAMYCIN INJECTION IN 5% DEXTROSE
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients CLINDAMYCIN CLINDAMYCIN
Strength(s) 600MG 600MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 600mg/50mL 600mg/50mL
ATC code J01FF J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-09-02 2020-09-02
Actual start date 2020-09-02 2020-09-02
Estimated end date 2020-09-16 2020-09-16
Actual end date 2020-09-16
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments